1Yokoyama Y,Green JE.Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinoma in a transgenic mouse model[J].Cancer Res,2000,60(16):4362-4365.
2Bertolini F,Fusetti L,Mancuso P,et al.Endostatin,an antiangiogenic drug induces tumor stabilization after chemotherapy or anti-CD20 therapy in a NOD/SCID mouse model of human high-grade non-Hodgkin lymphoma[J].Blood,2000,96(1):282-287.
3Boehm T,Folkman J,Browder T,et al.Anti-angiogenic therapy of experimental cancer does not induce acquired drug resistance[J].Nature,1997,390(6658):404-407.
4Rapraeger AC,Krufka A,Olwin BB.Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differention[J].Science,1991,252:1705-1708.
5Erger AC,Feldman A L.The angiogenesis inhibitor,endostatin,does not affect murine cutaneous wound healing[J].J Sur Res,2000,91(1):26-31.
6O'Reilly MS,Bohem T,Folkman J,et al.Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J].Cell,1997,88(2):277-285.
8Panek RI,Lu GH,Dahring TK,et al.In vitro biological characterization and antiangiogenic effects of PD 166866,a selective inhibitor of the FGF-1 receptor tyrosine kinase[J].J Pharmacol Exp Ther,1998,286(1):569-577.
9Vu TH,Shipley JM,Bergers G,et al.MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertropic chondrocytes[J].Cell,1998,93 (3):411-422.
10Friedlander M,Theesfeld CL,Sugita M,et al.Involvement of integrins avβ3 and avβ5 in ocular neovacular diseases[J].Proc Natl Acad Sci USA,1996,93(18):9764-9769.
